AI
Recursion and NVIDIA partner for AI-enabled drug discovery developments
July 13, 2023Research and Development AI, Pharmacy, Recursion, drug discovery
Clinical stage biotech company Recursion has announced a $50m investment by NVIDIA, intended to accelerate the development of its AI …
Anavex Life Sciences and Partex NV Group announce AI-based strategic partnership to enhance patient experience
June 28, 2023Research and Development AI, Anavex Life Sciences, Partex NV Group, Pharmacy, patient experience
US-based clinical-stage biopharmaceutical company Anavex Life Sciences and German digital pharma platform Partex NV Group have announced a strategic partnership …
Scientists use AI to find new antibiotic to fight superbug
May 26, 2023Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance
Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …
Personalised medicine in oncology: Where are we now?
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery
The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Exscientia to collaborate with EQRx on drug development
June 25, 2021Medical Communications AI, Exscientia, clinical drug development
Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …
Novartis announce digital collaboration with HPE
June 24, 2021AI, HPE, Novartis
Swiss pharma company, Novartis, has announced a collaboration with Hewlett Packard Enterprise (HPE), to accelerate its use of data and …
UK AI firm wins share of £140 million funding for lung cancer detection tech
June 18, 2021Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology
Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …
Lucida Medical gains CE marking for AI prostate cancer tech
June 1, 2021Manufacturing and Production AI, MRI, NHS, prostate cancer
Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …
Ori Biotech and Vineti to collaborate on CGT manufacturing
May 26, 2021Research and Development AI, CGTs
Ori Biotech and Vineti have announced a strategic partnership to produce pre-integrated solutions to fast-track and streamline the manufacture and …
Exscientia and BMS announce $1.2 billion collaboration
May 19, 2021Research and Development AI
Artificial intelligence (AI) pharmatech company, Exscientia, has announced a collaboration with Bristol Myers Squibb to accelerate the discovery of small …
Oxford University to collaborate with Oracle on COVID variant research
May 17, 2021Sales and Marketing AI, COVID-19, Oxford, variants
In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …
PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes
May 17, 2021Sales and Marketing AI, drug discovery
PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …
Biogen to collaborate with Envisagenics on RNA splicing research
May 14, 2021Medical Communications AI
Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …
Exscientia launch trial of third AI-designed molecule
May 13, 2021AI, Altzeimer's, Exscientia
Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
